Articles By Jack Cush, MD
ACR Position on MOC Highlighted in Newsweek
Newsweek has reported that the American Board of Internal Medicine has struggled in the last year with increasing criticism over its requirements for maintenance of certification, or MOC.
Read Article
New Drugs, New Hope for Pulmonary Fibrosis
The Wall Street Journal reports that new drug development offers hope for people with idiopathic pulmonary fibrosis, a rare, progressive fibrosing lung disorder that affects nearly 200,000 Americans, mostly middle-aged and older adults.
Read Article
Gouty Tomatoes, Alveolar Hemorrhage and Famous RA Faces: August 2015 Top Social Media News
In August, RheumNow published 76 tweets covering novel news, research and teaching points gleaned from the medical literature, regulatory reports and internet sources. We had a reach (impressions) of 60,800, with 45 mentions, and 2049 visits to RheumNow.com.
Read Article
Diastolic Dysfunction in Rheumatoid Arthritis
Poor cardiovascular outcomes have been linked to inflammation and rheumatoid arthritis (RA). This includes higher rates of MI and heart failure (HF).
Read Article
Gout: New Classification Criteria from ACR/EULAR
The American College of Rheumatology and the European League against Rheumatism joined forces to finalize classification criteria for gout, a condition that affects 8.3 million Americans.
Read Article
A Controlled Trial of Yoga Benefits Arthritis Patients
Yoga and stretching appear to be important forms of exercise for patients with fibromyalgia, but their utility has seldom been explored in patients with rheumatoid or osteoarthritis.
Read Article
Can Fibromyalgia in Children be Treated Without Medication?
The hallmarks of fibromyalgia -- widespread pain, poor sleep, effort intolerance, fatigue -- are difficult to manage and usually require medication and a multi-modal approach.
Read Article
Age and Comorbidity Contribute to Higher Death Risk Following Hip Fracture Surgery
Patients undergoing surgery for a hip fracture appear to have higher death rates than those having elective total hip replacement.
Read Article
Funding for Rheumatology Research in Decline
The Rheumatology Research Foundation and Rheumatology News report that research projects funded by the National Institutes of Health (NIH) dropped by 52% from 2010 to 2014, while the number funded by private foundations fell by 29% over that period.
Read Article
Monitoring of Novel Therapies in Rheumatology
The rheumatology therapeutic landscape has changed almost yearly in the last 15 years, with the introduction of at least 16 biologic or novel agents for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), spondyloarthritis (SpA), juvenile arthritis,
Read Article
